F15.180
Other stimulant abuse with stimulant-induced anxiety disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F15.180 refers to a condition characterized by the misuse of stimulants, such as amphetamines or other similar substances, which leads to a specific mental health issue known as stimulant-induced anxiety disorder. This diagnosis encompasses situations where an individual abuses stimulant drugs and subsequently experiences significant anxiety symptoms directly attributable to the stimulant use. Recognizing this condition is essential for appropriate medical intervention and management.
Causes & Symptoms
Clinical Causes: Recreational or non-medical use of stimulant drugs like methamphetamine, cocaine, or prescribed stimulants used improperly Prolonged or high-dose use of stimulants leading to dependence Using stimulants in an attempt to enhance alertness, energy, or academic/work performance Co-occurring mental health conditions that may increase vulnerability to stimulant abuse
Key Symptoms: Persistent and intense anxiety or nervousness Restlessness or agitation Tremors or muscle twitching Rapid heartbeat or palpitations Difficulty sleeping or insomnia Episodes of panic or panic attacks Irritability or mood swings Feeling of impending doom or catastrophic thoughts Hypervigilance or heightened startle response
Diagnostic & Treatment
Diagnosis Path: Diagnosis of stimulant abuse with stimulant-induced anxiety disorder involves a comprehensive clinical assessment, including detailed patient history, physical examination, and mental health evaluation. Healthcare providers typically review drug use patterns, duration, and intensity of stimulant consumption, alongside the presentation of anxiety symptoms. Laboratory testing, such as urine or blood screens, may be used to confirm recent stimulant use. It is important to rule out other psychiatric disorders or medical conditions that could contribute to anxiety symptoms.
Treatment Protocols: Treating stimulant abuse and the associated anxiety symptoms often requires a multidisciplinary approach, which may include: - Behavioral therapies such as cognitive-behavioral therapy (CBT) to address substance use behaviors and manage anxiety - Support groups and counseling to provide emotional support and relapse prevention strategies - Medications, if appropriate, to manage anxiety symptoms, under careful medical supervision - Education about the effects of stimulant drugs and strategies to avoid relapse - Monitoring for co-occurring mental health issues that may need separate management Successful treatment often involves long-term commitment to recovery, with ongoing support to prevent relapse and address any ongoing mental health concerns.
Clinical Advice & FAQs
Billing Guidance
Is F15.180 a billable ICD-10 code?
Yes, F15.180 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F15.180?
Clinical documentation must specify the nature of Other stimulant abuse with stimulant-induced anxiety disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference